HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Medtronic Self-expanding TAVR Platform Shows Excellent Longer-term Performance at 5 Years in SURTAVI Trial

Data showed that the hemodynamic (blood flow) benefits of the Medtronic CoreValve™ and Evolut™ platforms were maintained at five years with an excellent safety profile and stable valve performance in patients with symptomatic, severe aortic stenosis who are at an intermediate risk for open-heart surgery.

New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome

CHEETAH clinical study of its Indigo® System CAT™ RX Catheter successfully met the primary endpoint and demonstrated high rates of blood clot removal, blood flow restoration and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in patients with high thrombus burden.

Wegovy™ Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity

The STEP 5 trial investigated Wegovy™ vs. placebo, both used with a reduced-calorie meal plan and increased physical activity for the treatment of obesity (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/ m2) in 304 adults with at least one weight-related comorbidity for 104 weeks (two years)

SPYRAL AFFIRM Study Shows Patients with High Blood Pressure Are Interested in an Interventional Procedure RX Option

SPYRAL AFFIRM study, also concluded that blood pressure reduction was the most important driver of patient preference over all other attributes like medication burden and treatment (including interventional treatment-related) risks.

Fogarty Innovation Graduate Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study

Innovative technology designed to keep mothers and babies safe during childbirth.

1st U.S. Patient Enrolled in Cardionomic’s CPNS System Pilot Study

The study is evaluating the safety and performance of the CPNS System in patients suffering from acute decompensated heart failure (ADHF), defined as new or worsening symptoms of heart failure. The first U.S. patient was enrolled and implanted at The Ohio State University Wexner Medical Center in Columbus, OH by Principal Investigator, Dr. Sitaramesh Emani, assisted by Dr. Rami Kahwash.

Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery

The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time. For investigational use (in New Zealand) only.  GPX-DOX Embolic Device is under development and does not have marketing clearance or approval in any market at this time.

VenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes

Tim Boire, CEO said, “After years of development, we are confident that our bioabsorbable wrap technology can have a positive impact on the lives of patients that require hemodialysis to sustain life.

CathVision Announces First Patient Enrollments in PVISION Multicenter Clinical Study

The PVISION study is the perfect opportunity to demonstrate the importance of enhanced EP recording technology and AI algorithms in shaping the future of diagnosing, characterizing and treating complex arrhythmias.